Northern Trust’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-349,366
| Closed | -$2.04M | – | 4537 |
|
|
2025
Q1 | $2.04M | Sell |
349,366
-9,054
| -3% | -$47.7K | ﹤0.01% | 2917 |
|
|
2024
Q4 | $1.33M | Buy |
358,420
+8,745
| +3% | +$40.4K | ﹤0.01% | 3246 |
|
|
2024
Q3 | $1.95M | Buy |
349,675
+14,305
| +4% | +$100K | ﹤0.01% | 3018 |
|
|
2024
Q2 | $2.82M | Sell |
335,370
-19,517
| -5% | -$208K | ﹤0.01% | 2720 |
|
|
2024
Q1 | $5.12M | Sell |
354,887
-4,302
| -1% | -$71.1K | ﹤0.01% | 2436 |
|
|
2023
Q4 | $7.73M | Buy |
359,189
+27,990
| +8% | +$499K | ﹤0.01% | 2241 |
|
|
2023
Q3 | $6.37M | Sell |
331,199
-2,038
| -0.6% | -$43.5K | ﹤0.01% | 2295 |
|
|
2023
Q2 | $8.47M | Sell |
333,237
-2,969
| -0.9% | -$85.7K | ﹤0.01% | 2182 |
|
|
2023
Q1 | $12.2M | Buy |
336,206
+1,799
| +0.5% | +$63.2K | ﹤0.01% | 1891 |
|
|
2022
Q4 | $13.2M | Buy |
334,407
+17,666
| +6% | +$735K | ﹤0.01% | 1817 |
|
|
2022
Q3 | $14.8M | Sell |
316,741
-2,864
| -0.9% | -$133K | ﹤0.01% | 1706 |
|
|
2022
Q2 | $14M | Sell |
319,605
-9,040
| -3% | -$497K | ﹤0.01% | 1779 |
|
|
2022
Q1 | $23.8M | Sell |
328,645
-14,283
| -4% | -$1.03M | ﹤0.01% | 1550 |
|
|
2021
Q4 | $27.8M | Sell |
342,928
-17,103
| -5% | -$1.71M | ﹤0.01% | 1544 |
|
|
2021
Q3 | $41.9M | Sell |
360,031
-2,785
| -0.8% | -$365K | 0.01% | 1225 |
|
|
2021
Q2 | $60.2M | Sell |
362,816
-25,414
| -7% | -$3.97M | 0.01% | 983 |
|
|
2021
Q1 | $54.2M | Sell |
388,230
-60,310
| -13% | -$9.84M | 0.01% | 1045 |
|
|
2020
Q4 | $77.6M | Sell |
448,540
-4,188
| -0.9% | -$678K | 0.02% | 769 |
|
|
2020
Q3 | $63.1M | Sell |
452,728
-13,873
| -3% | -$1.85M | 0.01% | 768 |
|
|
2020
Q2 | $55.7M | Buy |
466,601
+64,836
| +16% | +$7.69M | 0.01% | 813 |
|
|
2020
Q1 | $40.2M | Buy |
401,765
+15,933
| +4% | +$1.92M | 0.01% | 902 |
|
|
2019
Q4 | $45.4M | Sell |
385,832
-11,788
| -3% | -$1.17M | 0.01% | 1088 |
|
|
2019
Q3 | $34.2M | Buy |
397,620
+16,266
| +4% | +$1.23M | 0.01% | 1256 |
|
|
2019
Q2 | $24.7M | Buy |
381,354
+19,214
| +5% | +$1.2M | 0.01% | 1524 |
|
|
2019
Q1 | $22.6M | Sell |
362,140
-8,996
| -2% | -$423K | 0.01% | 1580 |
|
|
2018
Q4 | $14.4M | Sell |
371,136
-3,269
| -0.9% | -$145K | ﹤0.01% | 1836 |
|
|
2018
Q3 | $21.3M | Buy |
374,405
+8,445
| +2% | +$528K | 0.01% | 1743 |
|
|
2018
Q2 | $29.2M | Buy |
365,960
+38,999
| +12% | +$3.24M | 0.01% | 1470 |
|
|
2018
Q1 | $28.3M | Buy |
326,961
+2,294
| +0.7% | +$185K | 0.01% | 1427 |
|
|
2017
Q4 | $22.4M | Sell |
324,667
-10,531
| -3% | -$842K | 0.01% | 1620 |
|
|
2017
Q3 | $30.5M | Buy |
335,198
+10,268
| +3% | +$879K | 0.01% | 1370 |
|
|
2017
Q2 | $24.2M | Buy |
324,930
+41,647
| +15% | +$3.34M | 0.01% | 1529 |
|
|
2017
Q1 | $26.5M | Buy |
283,283
+4,477
| +2% | +$406K | 0.01% | 1418 |
|
|
2016
Q4 | $20.3M | Sell |
278,806
-22,995
| -8% | -$1.97M | 0.01% | 1609 |
|
|
2016
Q3 | $31.5M | Buy |
301,801
+11,319
| +4% | +$1.02M | 0.01% | 1208 |
|
|
2016
Q2 | $21.4M | Buy |
290,482
+89,294
| +44% | +$6.06M | 0.01% | 1471 |
|
|
2016
Q1 | $11.1M | Buy |
201,188
+13,408
| +7% | +$791K | ﹤0.01% | 1898 |
|
|
2015
Q4 | $12.7M | Sell |
187,780
-4,405
| -2% | -$236K | ﹤0.01% | 1827 |
|
|
2015
Q3 | $8.91M | Buy |
192,185
+74,830
| +64% | +$3.63M | ﹤0.01% | 2070 |
|
|
2015
Q2 | $6.31M | Buy |
117,355
+23,010
| +24% | +$1.17M | ﹤0.01% | 2368 |
|
|
2015
Q1 | $4.52M | Buy |
94,345
+15,452
| +20% | +$670K | ﹤0.01% | 2565 |
|
|
2014
Q4 | $3.05M | Buy |
+78,893
| New | +$2.48M | ﹤0.01% | 2819 |
|
Other funds holding NVRO
Northern Trust's NVRO Position: Q2 2025 in Review
Northern Trust sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 349,366 shares — an estimated $2.04M sold.
Northern Trust first reported a position in NVRO in Q4 2014 and held it in 42 quarters. The position peaked at $77.6M in Q4 2020. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.
- Northern Trust reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
- Northern Trust sold 349,366 NEVRO CORP. shares in Q2 2025, an estimated $2.04M.
- Northern Trust first reported a position in NEVRO CORP. in Q4 2014 and held it in 42 quarters.
- Northern Trust's NEVRO CORP. position peaked at $77.6M in Q4 2020.
- 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.
Based on Northern Trust's 13F filing for Q2 2025, filed 13 Aug 2025.